NCT02297672View on ClinicalTrials.gov

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant

NAActive, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2026

Conditions
Early Stage Breast Cancer
Interventions
RADIATION

Stranded palladium seed interstitial implant

Interstitial implantation of stranded palladium 103 seeds in seroma with a margin

DEVICE

3 dimensional breast ultrasound

guidance of placement of interstitial needles in breast

DEVICE

Computerized tomography (CT)

Breast CT for planning and assessing interstitial implantation of radioactive seeds

Trial Locations (1)

V1Y 5L3

BCCA Center for the Southern Interior, Kelowna

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT02297672 - Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant | Biotech Hunter | Biotech Hunter